Search results

Found 17935 matches for

Results from an insight review commissioned by the Wellcome Trust, highlights what is currently known about the benefits and risks of using selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression and anxiety in young people.

A boy in a hoodie sitting on a beach looking out to sea

Sarah Chen

Alex McKeown

PhD Alex McKeown - Visiting Scholar

Bergljot Gjelsvik

PhD, BA, MSt(Oxon), DClinPsy (Norwegian equivalent), Bergljot Gjelsvik - Research Clinical Psychologist

Philip Burnet

BSc(Hons), MSc, PhD Philip Burnet - Professor of Neuroscience

Philip Cowen

Philip Cowen - Professor of Psychopharmacology

Paul Harrison

MA, BM. BCh, DM (Oxon), FRCPsych Paul Harrison - Professor of Psychiatry; Associate Head of Department (Research)

Clare Mackay

BSc PhD (Liverpool) Clare Mackay - Professor of Neuroscience

Elizabeth Tunbridge

B.Sc. M.Sc. D.Phil. Elizabeth Tunbridge - Director of Translational Neuroscience, Boehringer Ingelheim

Shi Yu Chan

Shi Yu Chan - DPhil Student

Justin Lowen

Justin Lowen - Finance Manager

Beata Godlewska

Beata Godlewska - Clinical Researcher, Honorary Consultant Psychiatrist

Elizabeth Rapa

D.Phil Elizabeth Rapa - Associate Professor

Philip Wilkinson

BMedSci BM BS (Nottingham), FRCPsych, Dip Obst (Auckland, New Zealand), Certificate in Cognitive Therapy (Oxford), ATCL, LGSMD, CELTA Philip Wilkinson - Honorary Senior Clinical Lecturer